This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Diabetes insipidus is a rare, but serious, disorder of the body’s water balance, caused by a lack of a hormone called vasopressin. When the body does not produce enough vasopressin, it is unable to regulate the amount of water in the blood and urine. This results in excessive thirst and the production of large amounts of urine. Symptoms of diabetes insipidus include excessive thirst, frequent urination, and frequent nighttime urination. Diabetes insipidus is typically divided into two types: central and nephrogenic. Central diabetes insipidus is caused by a lack of vasopressin production by the pituitary gland. Nephrogenic diabetes insipidus is caused by a defect in the kidney’s ability to respond to vasopressin. Diagnosis of diabetes insipidus is typically made through a combination of a patient’s medical history, physical exam, laboratory tests, and imaging studies. Treatment options depend on the type of diabetes insipidus the patient has and may include hormone replacement therapy, medications, and/or lifestyle changes.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States